First Midwest Bank Trust Division’s Alexion Pharmaceuticals ALXN Stock Holding History

First Midwest Bank Trust Division’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-1,550	Closed	-$296K	–	430
2015 Q4	$296K	Buy	1,550 +100	+7%	+$17.5K	0.05%	293
2015 Q3	$227K	Buy	+1,450	New	+$264K	0.04%	355
2014 Q3	–	Sell	-2,760	Closed	-$431K	–	444
2014 Q2	$431K	Sell	2,760 -800	-22%	-$126K	0.07%	284
2014 Q1	$542K	Sell	3,560 -1,090	-23%	-$173K	0.09%	216
2013 Q4	$618K	Buy	+4,650	New	+$558K	0.11%	186

Other funds holding ALXN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

First Midwest Bank Trust Division's ALXN Position: Q1 2016 in Review

First Midwest Bank Trust Division sold out of Alexion Pharmaceuticals (ALXN) in Q1 2016, closing a stake of 1,550 shares — an estimated $296K sold.

First Midwest Bank Trust Division first reported a position in ALXN in Q4 2013 and held it in 5 quarters. The position peaked at $618K in Q4 2013. 520 funds tracked by Wall St. Rank hold ALXN as of Q1 2016.

First Midwest Bank Trust Division reported no remaining Alexion Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
First Midwest Bank Trust Division sold 1,550 Alexion Pharmaceuticals shares in Q1 2016, an estimated $296K.
First Midwest Bank Trust Division first reported a position in Alexion Pharmaceuticals in Q4 2013 and held it in 5 quarters.
First Midwest Bank Trust Division's Alexion Pharmaceuticals position peaked at $618K in Q4 2013.
520 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2016.

Based on First Midwest Bank Trust Division's 13F filing for Q1 2016, filed 27 Apr 2016.